Microbot Medical (NASDAQ:MBOT) Posts Earnings Results, Misses Expectations By $0.02 EPS

Microbot Medical (NASDAQ:MBOT - Get Free Report) announced its quarterly earnings data on Wednesday. The biotechnology company reported ($0.20) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.18) by ($0.02), Zacks reports.

Microbot Medical Stock Down 4.6 %

Shares of Microbot Medical stock traded down $0.07 during mid-day trading on Friday, reaching $1.46. 497,816 shares of the stock traded hands, compared to its average volume of 1,779,625. Microbot Medical has a fifty-two week low of $0.82 and a fifty-two week high of $3.38. The stock has a market capitalization of $50.73 million, a PE ratio of -1.82 and a beta of 1.60. The business has a 50-day moving average of $1.74 and a 200 day moving average of $1.32.

Analysts Set New Price Targets

Separately, HC Wainwright increased their price target on Microbot Medical from $7.00 to $9.00 and gave the company a "buy" rating in a report on Friday, January 24th.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.